Oral Presentations
Early Diagnosis of Hypertrophic Obstructive Cardiomyopathy in Young Athletes
Location
Sydnor Performance Hall, Schewel Hall
Access Type
Campus Access Only
Entry Number
70
Start Date
4-10-2019 9:30 AM
End Date
4-10-2019 9:45 AM
College
College of Business
Department
Physician Assistant
Abstract
Hypertrophic Obstructive Cardiomyopathy (HOCM) is a life-threatening genetic cardiovascular disease that is often linked to sudden cardiac death in young athletes regardless of sex and race. HOCM occurs in 1 out of 500 individuals and is an autosomal dominant genetically transmitted disorder which results from a mutation in one of nine sarcomere proteins’ genetic make up. The purpose of this literature review is to analyze the screening tools that are currently being used to diagnose HOCM. The American Heart Association recommends that athletes should have a history and physical examination every 2 years; however, these are not reliable methods to identify those with increased risk of HOCM. Fox et. al performed a study that consisted of 2,332 young athletes screened for HOCM based on the thickness of the heart septum to posterior wall ratio determined via point of care ultrasonography. From this 6% of the individuals had an increased ratio greater than 1.25 indicating a risk of HOCM. The gold standard diagnostic test of HOCM is trans-thoracic echocardiogram. From this study, we will evaluate the effectiveness and feasibility of screening tools for early diagnosis of HOCM in young athletes.
Faculty Mentor(s)
Dr. Joyce Nicholas
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
Final Presentation
Early Diagnosis of Hypertrophic Obstructive Cardiomyopathy in Young Athletes
Sydnor Performance Hall, Schewel Hall
Hypertrophic Obstructive Cardiomyopathy (HOCM) is a life-threatening genetic cardiovascular disease that is often linked to sudden cardiac death in young athletes regardless of sex and race. HOCM occurs in 1 out of 500 individuals and is an autosomal dominant genetically transmitted disorder which results from a mutation in one of nine sarcomere proteins’ genetic make up. The purpose of this literature review is to analyze the screening tools that are currently being used to diagnose HOCM. The American Heart Association recommends that athletes should have a history and physical examination every 2 years; however, these are not reliable methods to identify those with increased risk of HOCM. Fox et. al performed a study that consisted of 2,332 young athletes screened for HOCM based on the thickness of the heart septum to posterior wall ratio determined via point of care ultrasonography. From this 6% of the individuals had an increased ratio greater than 1.25 indicating a risk of HOCM. The gold standard diagnostic test of HOCM is trans-thoracic echocardiogram. From this study, we will evaluate the effectiveness and feasibility of screening tools for early diagnosis of HOCM in young athletes.